SR One
SR One is a transatlantic biotechnology venture capital firm that partners with founders to translate innovative science into medicines. The firm describes a "back-and-build" investment approach and positions teams in West Coast USA and London to provide regional expertise and real-time business support to portfolio companies.
Industries
Nr. of Employees
small (1-50)
SR One
929 Main Street, Suite 200, Redwood City, CA 94063, United States
Portfolio
Focus: whole-gene insertion technologies. Geography: South San Francisco, USA.
#Other
RNA targeting platform; CEO: Zhen Li, PhD. Geography: San Diego, USA.
#Rare diseases
Clinical-stage biologic treatments for oncology and inflammatory diseases. CEO: Ben Buelow, MD, PhD. Geography: Palo Alto, USA.
#Immunology
Developing next-generation TYK2 inhibitors for autoimmune diseases. CEO: Martin Babler. Geography: South San Francisco, CA.
#Immunology
Developing an epinephrine nasal spray for severe allergies. CEO: Richard Lowenthal. Geography: San Diego, USA.
#Immunology
Focus: whole-gene insertion technologies. Geography: South San Francisco, USA.
#Other
RNA targeting platform; CEO: Zhen Li, PhD. Geography: San Diego, USA.
#Rare diseases
Clinical-stage biologic treatments for oncology and inflammatory diseases. CEO: Ben Buelow, MD, PhD. Geography: Palo Alto, USA.
#Immunology
Developing next-generation TYK2 inhibitors for autoimmune diseases. CEO: Martin Babler. Geography: South San Francisco, CA.
#Immunology
Developing an epinephrine nasal spray for severe allergies. CEO: Richard Lowenthal. Geography: San Diego, USA.
#Immunology